The effect of rivastigmine on sleep in elderly healthy subjects

Experimental Gerontology

Volumn 35, Issue 2, 2000, Pages 243-249

  Schredl, Michael ^a   Weber, Bettina ^a   Braus, Dieter ^a   Heuser, Isabella ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Cognitive functioning; Elderly; REM sleep; Rivastigmine

Indexed keywords

CHOLINESTERASE INHIBITOR; PLACEBO; RIVASTIGMINE;

ADULT; AGED; AROUSAL; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLEEP PATTERN; VOLUNTEER;

AGED; AGING; ANALYSIS OF VARIANCE; CARBAMATES; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENYLCARBAMATES; REFERENCE VALUES; SLEEP, REM;

EID: 0034031963     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(00)00077-2     Document Type: Article

References (25)

1. Berkowitz A., Sutton L., Janowsky D.S., Gillin J.C. Pilocarpine, an orally active muscarine cholinergic agonist, induces REM sleep and reduces delta sleep in normal volunteers. Psych Res. 33:1990;113-119.
2. Bliwise D.L. Sleep in normal aging and dementia. Sleep. 16:1993;40-81.
3. Dykierek, P, Stadtmüller, G, Schramm, P, et al. (0000). The value of REM sleep parameters in differentiating Alzheimer's disease from old-age depression and normal aging. J Psych Res 32, 1-9.
4. Ellman, SJ, Spielman AJ, Luck, D, Steiner, SS, & Halperin, R (1991). REM deprivation: a review. In Ellman SJ, Antrobus JS, (Eds), The mind in sleep - psychology and psychophysiology. New York: John Wiley. pp. 327-76.
5. Farlow, MR (1998). Etiology and pathogenesis of Alzheimer's disease. Am J Health System Pharm Suppl 55, S5-S10.
6. Friess, E, Trachsel, L, Guldner, J, Schier, T, Steiger, A, & Holsboer F (1995). DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol 268, E107-E13.
7. Hennevin E., Hars B., Maho C., Bloch V. Processing of learned information in paradoxical sleep relevance for memory . Behav Brain Res. 69:1995;125-135.
8. Hobson, J A, Stickgold, R, & Pace-Schott, EF, (1998). The neuropsychology of REM sleep dreaming. Neuroreport 9, R1-R14.
9. Hohagen F., Riemann D., Spiegel R., Holzhauer M., Berger M. Influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects. Neuropsychopharmacology. 9:1993;225-232.
10. Holsboer-Trachsler, E, Hatzinger, M, Stohler, R, et al. (1993). Effects of the novel acetylcholinesterase inhibitor SDZ ENA 713 on sleep in men. Neuropsychopharmacology 8, 87-92.
11. Jann W.W. Pharmacology and clinical efficacy of cholinesterase inhibitors. Am J Health System Pharm Suppl. 55:1998;S22-S25.
12. Knopman D.S. Current pharmacotherapies for Alzheimer's disease. Geriat Suppl. 53:1998;S31-S34.
13. Lauriello J., Kenny W.M., Sutton L., Golshan S., Ruiz C., Kelsoe J., Rapaport M., Gillin J.C. The cholinergic REM sleep induction test with pilocarpine in mildly depressed and normal controls. Biolog Psych. 33:1993;33-39.
14. Mesulam M.M. Some cholinergic themes related to Alzheimer's disease synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity . J Physiol (Paris). 92:1998;293-298.
15. Polinsky R.J. Clinical pharmacology of rivastigmine a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease . Clin Therapeut. 20:1998;634-646.
16. Rechtschaffen A, & Kales, A (1968). A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Washington, U. S. Public Health Service.
17. Riemann D., Gann H., Dressing H., Müller W.E., Aldenhoff J.B. Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep. Psych Res. 51:1994;253-267.
18. Riemann D., Joy D., Höchli D., Lauer C., Zulley J., Berger M. Influence of the cholinergic agonist RS 86 on normal sleep sex and age differences . Psych Res. 24:1988;137-147.
19. Riemann, D, Lis, S, Fritsch-Montero R, et al. (1996). Effect of tetrahydroaminoacridine on sleep in healthy subjects. Biolog Psych 39, 796-802.
20. Sitaram N., Moore A.M., Gillin J.C. Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist. Nature. 274:1978;490-492.
21. Sitaram N., Moore A.M., Gillin J.C. Induction and resetting of REM sleep rhythm in normal men by acecholin blockade by scopolamine . Sleep. 1:1978;83-90.
22. Sitaram N., Wyatt R.J., Dawson S., Gillin J.C. REM sleep induction by physiostigmine infusion during sleep. Science. 191:1976;1281-1283.
23. Smith C. Sleep states and memory processes. Behav Brain Res. 69:1995;137-145.
24. Spiegel R. Effects of RS86, an orally active cholinergic agonist, on sleep in man. Psych Res. 11:1984;1-13.
25. Tariot P.N., Patel S.V., Cox C., Henderson R.E. Age-related decline in central cholinergic function demonstrated with scopolamine. Psychopharmacology. 125:1996;50-56.